Top Markets
#1 PulseChain PulseChain +45.01%
#2 RedStone RedStone +18.29%
#3 Glidr Glidr +11.78%
#4 SkyAI SkyAI +10.14%
#5 Bitway Bitway +9.91%
#6 OPENLOOT OPENLOOT +8.58%
#7 Unit Pump Unit Pump +7.99%
#8 Pump.fun Pump.fun +7.99%
#9 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.71%
#10 Monad Monad +6.79%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Oncocross Co., Ltd. Oncocross Co., Ltd.

Oncocross Co., Ltd.

382150
Rank in Stocks #27845
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover... Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Share Price
$2.49
Market Cap
$30.36M
Change (1 day)
6.67%
Change (1 year)
-59.72%
Country
KR
Trade Oncocross Co., Ltd. (382150)

Category

Healthcare
EPS for Oncocross Co., Ltd. (382150)
EPS as of 2026 TTM: 0
According to Oncocross Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Oncocross Co., Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH